| Online-Ressource |
Verfasst von: | Radu, Christian Andreas [VerfasserIn]  |
| Gebhard, Martha-Maria [VerfasserIn]  |
| Germann, Günter [VerfasserIn]  |
| Terness, Peter [VerfasserIn]  |
Titel: | Local administration of Mitomycin-C-Treated peripheral blood mononuclear cells (PBMCs) prolongs allograft survival in vascularized composite allotransplantation |
Verf.angabe: | Christian Andreas Radu, Jurij Kiefer, Martha Maria Gebhard, Amir Khosrow Bigdeli, Volker Jürgen Schmidt, Guenter Germann, Marcus Lehnhardt, Peter Terness, Ulrich Kneser, andThomas Kremer |
Jahr: | 2016 |
Umfang: | 9 S. |
Teil: | volume:36 |
| year:2016 |
| number:5 |
| pages:417-425 |
| extent:9 |
Fussnoten: | Published online: 17 November 2015 ; Gesehen am 02.02.2018 |
Titel Quelle: | Enthalten in: Microsurgery |
Ort Quelle: | New York, NY [u.a.] : Wiley-Liss, 1979 |
Jahr Quelle: | 2016 |
Band/Heft Quelle: | 36(2016), 5, Seite 417-425 |
ISSN Quelle: | 1098-2752 |
Abstract: | Background: VCA offers a potential treatment for extensive tissue defects. First results of systemic administration of Mitomycin C-treated PBMCs in VCA demonstrated a significant prolongation of allograft survival. The aim of this study is to evaluate if local administration of MMC-PBMCs prolongs allograft survival in allogeneic hind limb transplantations of the rat. Methods: Sixty allogeneic hind limb transplantations in the rat were performed in six groups. Lewis rats (LEW) were used as hind limb donors and Brown-Norway rats (BN) as recipients. Animals in group A received donor-derived MMC-treated PBMCs locally (i.m.). Group B received no immunosuppressive therapy, group C received a standard immunosuppressive regime consisting of FK506 and Prednisolon, group D (BN to BN) comprised isograft transplantations without immunosuppressive treatment, group E received non-treated PBMCs (i.m.) and group F received phosphate buffered saline (PBS) without cells. The transplanted hind limbs were assessed for color, edema, skin, hair condition, and consistency of the thigh every 8 hours. Results: Rejection in group A was delayed to an average of 7.2 ± 0.6 days. Survival times were significantly prolonged (P < 0.01) compared to control groups B, E, and F (5.5 ± 0.7, 5.8 ± 0.7, and 5.7 ± 0.5 days). Control groups C and D showed no signs of rejection. Conclusion: The findings of this study show that local administration of MMC-PBMCs has no side effects and significantly extends allograft survival. Further experiments with MMC-PBMCs treatments repeated at different time-points and being added to low dose immunosuppressive protocols need to be performed to improve experimental and eventually clinical outcome after VCA. © 2015 Wiley Periodicals, Inc. Microsurgery 36:417-425, 2016. |
DOI: | doi:10.1002/micr.30003 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: http://dx.doi.org/10.1002/micr.30003 |
| Volltext: http://onlinelibrary.wiley.com/doi/10.1002/micr.30003/abstract |
| DOI: https://doi.org/10.1002/micr.30003 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1568033591 |
Verknüpfungen: | → Zeitschrift |
Local administration of Mitomycin-C-Treated peripheral blood mononuclear cells (PBMCs) prolongs allograft survival in vascularized composite allotransplantation / Radu, Christian Andreas [VerfasserIn]; 2016 (Online-Ressource)